Zvast Biotechnology
Cell line-derived xenograft (CDX) tumor models are established by inoculating human tumor cells cultured in vitro into immunodeficient mice. These models are characterized by short modeling time, good reproducibility, and low cost. As a classic in vivo experimental method, CDX tumor models are in high demand for oncology research and anti-tumor drug development. Currently, Nanmo Biotech has established a large CDX model resource library, containing more than 60 cell lines covering tissues and organs throughout the body, and can provide various effective human tumor cell line xenograft efficacy models. We can also provide multiple pharmacological evaluation methods, including tumor growth curves, body weight curves, biochemical indicators, pathological analyses, as well as mRNA and protein level detection, to meet your diverse needs for drug pharmacodynamics evaluation and analysis.
